Strong April sales trigger 30% increase in Harris’ share price
Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.
In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.
The below articles were written under our previous business model. We have kept these articles online here for your reference.
Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.
Click Here to View Latest Articles
Harris Technology Group Limited (ASX:HT8) provided a promising trading update on Tuesday, resulting in its shares increasing more than 30%.
In mid-April, Harris announced that unaudited revenue for the March 2020 quarter had significantly increased and was expected to be sustained at similar levels for the foreseeable future.
It was at that time that the group established the Pro-Hygiene range of products including facemasks, hand sanitiser gels and alcohol wipes.
Harris has been authorised by China’s Jointown Pharmaceutical Group (one of the leading medical supply and distribution companies in China) to distribute its Jointown and Aumacom face masks.
The company sold an initial 30,000 face masks in March, and a new shipment of 200,000 TGA approved face masks were imported for sale in late April.
Revenue from the Pro-Hygiene range for the June 2020 quarter was estimated to be $400,000.
Sales revenue for April 2020 for both the IT/CE (Consumer Electronics Division) and the Pro-Hygiene division was just over $2.7 million.
This compares with sales revenue (unaudited) for the full March 2020 quarter of $3.4 million and sales for the April - June 2019 quarter (audited) of $2.23 million.
Having already eclipsed June 2019 quarter sales, as well as sales generated in the March 2020 quarter in just one month, Harris is positioned to finish the fiscal year strongly.
E-commerce business also tracking while
Sales of Pro-Hygiene products alone for April 2020 were $1.05 million (unaudited) with strong gross margins of 20%.
Consequently, in just one month Pro-Hygiene sales have exceeded the June quarter guidance by 150%.
Harris has expanded its product range by securing the non-exclusive Australian distribution rights for the “Tender Kiss” brand of alcohol tissues from Guangzhou Baihua Sanitary Products Co.
The tissues are being imported from China and sales of the brand will commence this month.
Harris is confident that supplies of products in China should continue, and the distribution rights are ongoing with no specific termination date.
A national network of sales agents to sell Pro-Hygiene products has been established, and one agent has been appointed for each state of Australia.
Harris had another record-breaking month, generating substantial sales growth through its IT/CE e-commerce business in April 2020. Unaudited sales revenue was $1.68 million.
Management will be providing a profit update in the coming weeks, which based on recent developments could be a share price catalyst.
General Information Only
This material has been prepared by Jason Price. Jason Price is an authorised representative (AR 000296877) of 62 Consulting Pty Limited (ABN 88 664 809 303) (AFSL 548573) (62C), and a Director of S3 Consortium Pty Ltd (trading as StocksDigital).
This material is general advice only and is not an offer for the purchase or sale of any financial product or service. The material is not intended to provide you with personal financial or tax advice and does not take into account your personal objectives, financial situation or needs. Although we believe that the material is correct, no warranty of accuracy, reliability or completeness is given, except for liability under statute which cannot be excluded. Please note that past performance may not be indicative of future performance and that no guarantee of performance, the return of capital or a particular rate of return is given by 62C, Jason Price, StocksDigital, any of their related body corporates or any other person. To the maximum extent possible, 62C, Jason Price, StocksDigital, their related body corporates or any other person do not accept any liability for any statement in this material.
Conflicts of Interest Notice
S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.
Publication Notice and Disclaimer
The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.
Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.
This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.
